Year archive

AIM Vaccine Co., Ltd. — 2026 filings

All 18 regulatory filings released by AIM Vaccine Co., Ltd. (6660) in 2026, sourced directly from the official regulator.

18 Filings

2026 Period

2026 filings (18)

Filing	Released	Lang
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON JUNE 10, 2026 Proxy Solicitation & Information Statement	2026-05-21	English
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2026-05-21	English
PROPOSED APPLICATION BY THE COMPANY FOR THE A SHARE LISTING ON THE BEIJING STOCK EXCHANGE AND ISSUANCE OF DOMESTIC SHARES UNDER SPECIFIC MANDATE Proxy Solicitation & Information Statement	2026-05-21	English
FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 10, 2026 Proxy Solicitation & Information Statement	2026-05-18	English
NOTICE OF 2025 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2026-05-18	English
(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED ELECTION OF DIRECTORS; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RULES OF PROCEDURES OF THE BOARD OF DIRECTORS Board/Management Information	2026-05-18	English
CIRCULAR OF 2025 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2026-05-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-06	English
2025 ANNUAL REPORT Regulatory Filings	2026-04-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-02	English
INSIDE INFORMATION PROPOSED APPLICATION BY THE COMPANY FOR THE A SHARE LISTING ON THE BEIJING STOCK EXCHANGE AND ISSUANCE OF DOMESTIC SHARES UNDER SPECIFIC MANDATE Share Issue/Capital Change	2026-03-30	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-03-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-03	English
VOLUNTARY ANNOUNCEMENT WORLD'S FIRST SERUM-FREE ITERATIVE RABIES VACCINE SUCCESSFULLY PASSED ON-SITE INSPECTION FOR REGISTRATION Regulatory Filings	2026-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-04	English
VOLUNTARY ANNOUNCEMENT APPROVAL FOR CLINICAL TRIALS OF THE 20-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE Regulatory Filings	2026-01-19	English
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL ON-SITE WORK COMPLETED FOR ITERATIVE PROCESS HIGH-POTENCY HUMAN DIPLOID CELL RABIES VACCINE Regulatory Filings	2026-01-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-02	English